Pre-embryos made in lab could spur research, ethics debates

For the first time, scientists have used human cells to make structures that mimic the earliest stages of development, which they say will pave the way for more research without running afoul of restrictions on using real embryos.

Two papers published Wednesday in the journal Nature detail how two teams of scientists independently made such structures.

They stressed that their work is only for research, not reproduction, but it likely will pose new ethical questions.

“Studying early human development is really difficult. It’s basically a black box,” said Jun Wu, a stem cell biologist at the University of Texas, Southwestern Medical Center.

“We believe our model can open up this field,” he said, if “you can test your hypothesis without using human embryos.”

Wu’s team used embryonic stem cells and the second team used reprogrammed skin cells to produce balls of cells that resemble one of the earliest stages of human development.

These balls, called blastocysts, form a few days after an egg has been fertilized but before the cells attach to the uterus to become an embryo. To differentiate their models from blastocysts created through fertilization, the researchers refer to the structures as “iBlastoids” and “human blastoids.”

“They shouldn’t be considered as equal to a blastocyst, although they are an excellent model for some aspects of biology,” said Jose Polo, an epigeneticist at Monash University in Australia who led the second research team.

Both groups stressed that the structures they made were not the same as naturally occurring embryos, and it’s unclear whether they could develop into viable embryos.

“The blastoids are less efficient in terms of generating structures mimicking later stage human embryos,” said Wu, whose team stopped growing the structure in a culture after four days.

Scientists previously generated similar structures of mouse cells in a lab, but this is the first time they have been made from human cells. The new models correspond to about three to 10 days after fertilization, Wu said. Last year, researchers unveiled structures that model cells 18 to 21 days after fertilization.

Research involving human embryos and blastocysts is currently ineligible for federal funding in the U.S., and several states prohibit it outright.

Some scientists now use blastocysts donated from fertility clinics for research into the causes of infertility and congenital diseases. The new work should allow them to do such research at much larger scales, Polo said.

“This capacity to work at scale will revolutionize our understanding of these early stages of human development,” said Polo.

The scientists stressed that their creations were not intended to be used for human reproduction.

“There is no implantation,” said Amander Clark, a stem cell biologist at the University of California, Los Angeles who co-authored the paper with Polo. “These structures are not transferred to a uterus or uterus-like structure,” she said. “There is no pregnancy.”

The distinction between blastocysts derived from fertilization and the structures created in a lab may not be so clear-cut, said Shoukhrat Mitalipov, a human embryologist at Oregon Health and Science University who was not involved in the research.

“Both groups show how closely they resemble real embryos,” he said. “If they are really as good as embryos, should they be treated as embryos?”

“This brings new ethical issues,” he said. “Are they going to be covered as human embryos? Should restrictions apply?”

Scientists previously tried to turn the lab-generated mouse cell structures into embryos, but they were not successful.

The optimal scenario for research is to “get as close to a real embryo as possible so you can learn from it, but not a real embryo so you don’t get into debates about the moral status of embryos,” said Alta Charo, a professor emerita of law and bioethics at University of Wisconsin who was not involved in the papers.



Source link

Blog article

Healthcare’s supply chain poses the next big environmental challenge

Healthcare companies in recent years have largely focused on reducing greenhouse gas emissions as they strive to become more environmentally sustainable. While that focus has produced several innovations in conservation and alternative energy use, critics argue those actions have only scratched the surface of reducing healthcare’s climate footprint. Hospitals have remained one of the world’s […]

Read More
Blog article

Cerner to lay off 150 workers next month

New Cerner CEO Dr. David Feinberg on Thursday told employees that a set of layoffs will take place in November, a company spokesperson confirmed to Modern Healthcare. Feinberg, who took the helm as Cerner’s CEO on Oct. 1 following nearly three years leading Google Health, sent an email to employees Thursday evening after noticing a […]

Read More
Blog article

Expert panel takes up complicated COVID-19 booster questions

Influential government advisers are deciding Thursday how best to expand the nation’s COVID-19 booster campaign, including whether and when it’s OK to “mix and match” brands for the extra dose. The advisers to the Centers for Disease Control and Prevention are slated to discuss who should get extra doses of the Moderna or Johnson & […]

Read More